311 related articles for article (PubMed ID: 17898301)
1. Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid.
Berkowitz BA; Roberts R; Stemmler A; Luan H; Gradianu M
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4753-8. PubMed ID: 17898301
[TBL] [Abstract][Full Text] [Related]
2. Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy.
Luan H; Roberts R; Sniegowski M; Goebel DJ; Berkowitz BA
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):320-8. PubMed ID: 16384980
[TBL] [Abstract][Full Text] [Related]
3. High-resolution manganese-enhanced MRI of experimental retinopathy of prematurity.
Berkowitz BA; Roberts R; Penn JS; Gradianu M
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4733-40. PubMed ID: 17898298
[TBL] [Abstract][Full Text] [Related]
4. alpha-lipoic acid corrects late-phase supernormal retinal oxygenation response in experimental diabetic retinopathy.
Roberts R; Luan H; Berkowitz BA
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4077-82. PubMed ID: 16936127
[TBL] [Abstract][Full Text] [Related]
5. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI.
Berkowitz BA; Roberts R; Goebel DJ; Luan H
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2668-74. PubMed ID: 16723485
[TBL] [Abstract][Full Text] [Related]
7. Normalization of retinal vascular permeability in experimental diabetes with genistein.
Nakajima M; Cooney MJ; Tu AH; Chang KY; Cao J; Ando A; An GJ; Melia M; de Juan E
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2110-4. PubMed ID: 11481279
[TBL] [Abstract][Full Text] [Related]
8. Early lipoic acid intake protects retina of diabetic mice.
Johnsen-Soriano S; Garcia-Pous M; Arnal E; Sancho-Tello M; Garcia-Delpech S; Miranda M; Bosch-Morell F; Diaz-Llopis M; Navea A; Romero FJ
Free Radic Res; 2008 Jul; 42(7):613-7. PubMed ID: 18608516
[TBL] [Abstract][Full Text] [Related]
9. Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress.
Yülek F; Or M; Ozoğul C; Isik AC; Ari N; Stefek M; Bauer V; Karasu C
Arch Med Res; 2007 Jul; 38(5):503-11. PubMed ID: 17560455
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats.
Hatcher HC; Ma JX; Chao J; Chao L; Ottlecz A
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):658-64. PubMed ID: 9071220
[TBL] [Abstract][Full Text] [Related]
11. Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.
Berkowitz BA; Ito Y; Kern TS; McDonald C; Hawkins R
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2964-9. PubMed ID: 11687543
[TBL] [Abstract][Full Text] [Related]
12. Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy.
Berkowitz BA; Roberts R; Luan H; Peysakhov J; Knoerzer DL; Connor JR; Hohman TC
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2954-60. PubMed ID: 16043871
[TBL] [Abstract][Full Text] [Related]
13. Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats.
Bucolo C; Leggio GM; Drago F; Salomone S
Biochem Pharmacol; 2012 Jul; 84(1):88-92. PubMed ID: 22484312
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[TBL] [Abstract][Full Text] [Related]
15. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Rota R; Chiavaroli C; Garay RP; Hannaert P
Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
[TBL] [Abstract][Full Text] [Related]
16. Blocking ET-1 receptors does not correct subnormal retinal oxygenation response in experimental diabetic retinopathy.
Roberts R; Luan H; Berkowitz BA
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3550-5. PubMed ID: 16877428
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.
Kowluru RA; Menon B; Gierhart DL
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1645-51. PubMed ID: 18385086
[TBL] [Abstract][Full Text] [Related]
18. Subnormal retinal oxygenation response precedes diabetic-like retinopathy.
Berkowitz BA; Kowluru RA; Frank RN; Kern TS; Hohman TC; Prakash M
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2100-5. PubMed ID: 10440266
[TBL] [Abstract][Full Text] [Related]
19. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of a coumarin derivative in diabetic rats.
Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
